SRTS · Sensus Healthcare, Inc. · Investor Relations
$2.36
+0.06 (+2.61%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$38.85M
Shares
16.46M
Volume · Nov 19
170.43K
Avg daily vol (3M)
205.66K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-11-12 | Sensus Healthcare, Inc. Q3 FY2026 Earnings Call | Earnings call |
| 2026-08-13 | Q2 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-05-07 | First Quarter 2026 Financial Results Conference Call | Earnings call |
| 2026-02-12 | Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer | Earnings call |
| 2025-11-06 | Third Quarter 2025 Financial Results Conference Call | Earnings call |
| 2025-08-07 | Second Quarter 2025 Financial Results Conference Call | Earnings call |
Key facts
CIK
1494891
CUSIP
81728J109
13F (30d)
42 filings
36 filers
Visit website
Investor relations